2 results match your criteria: "General Campus-Centre for Practice Changing Research[Affiliation]"
Management of pregnancy associated venous-thromboembolism: a survey of practices.
Thromb J
June 2014
Thrombosis Program, Division of Hematology, Department of Medicine, University of Ottawa-The Ottawa Hospital, Ottawa, Canada ; Clinical Epidemiology Unit, Ottawa Health Research Institute, Ottawa, Canada.
Introduction: Low-molecular-weight heparin (LMWH) is frequently recommended for the treatment of pregnancy associated venous thromboembolism (PAVTE). Given that prior reports have suggested a wide variation in dosing of LMWH in pregnancy and the use of anti-Xa monitoring in pregnancy, the principal aim of this survey was to assess current practices for the management of PAVTE.
Methods: An electronic survey was conducted.
Intermediate doses of low-molecular-weight heparin for the long-term treatment of pregnancy thromboembolism. A systematic review.
Thromb Haemost
March 2014
Dr. Marc Rodger, Thrombosis Program, Ottawa Hospital-Ottawa Hospital Research Institute, General Campus-Centre for Practice Changing Research, 501 Smyth Road, Rm L2265e, Box 201A, Ottawa, Ontario K1H 8L6, Canada, Tel.: +1 613 737 8899 ext 79084, Fax: +1 613 739 6102, E-mail: